Yayın:
Prepulse inhibition based grouping of rats and assessing differences in response to pharmacological agents

dc.contributor.authorOral, Sema
dc.contributor.buuauthorGöktalay, Gökhan
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıbbi Farmakoloji Ana Bilim Dalı
dc.contributor.orcid0000-0001-6261-4233
dc.contributor.researcheridJGN-6548-2023
dc.contributor.scopusid6508023759
dc.date.accessioned2024-02-02T11:26:27Z
dc.date.available2024-02-02T11:26:27Z
dc.date.issued2021-04-19
dc.description.abstractSchizophrenia modeling by disrupting prepulse inhibition (PPI) is one of the most frequently used psychopharmacological methods by administering pharmacological agents to stimulate disruption. However, since PPI is also a biological indicator of schizophrenia, it is possible to classify subjects based on their basal PPI values and group them as "low inhibition" and "high inhibition without taking any pharmacological agent. Therefore this study was conducted to show that rats can be divided into groups in terms of susceptibility to schizophrenia according to basal PPI values. It was also observed that these groups might give different responses to different pharmacological agents (apomorphine, amphetamine, MK-801, scopolamine, nicotine, caffeine). Male Sprague Dawley rats (250-350 g) were used in the study. To examine the effects of different pharmacological agents on the groups, apomorphine (0.5 mg/kg and 1 mg/kg), amphetamine (4 mg/kg), MK-801 (0.05 mg/kg and 0.15 mg/kg), scopolamine (0.4 mg/kg), nicotine (1 mg/kg) and caffeine (10 mg/kg and 30 mg/kg) were used. Amphetamine showed a disruptive effect on PPI in both low and high inhibitory groups, while apomorphine, MK801, scopolamine, and nicotine showed PPI decrease only in the high inhibitory group. Besides, caffeine decreased PPI levels at two doses in the high inhibitory group; however, 10 mg/kg dose caffeine was increased only in the low inhibitory group. According to the data obtained from this study, rats can be grouped with baseline inhibition values by using PPI, and response differences of pharmacological agents to groups may vary.
dc.identifier.citationOral, S. ve Göktalay, G. (2021). "Prepulse inhibition based grouping of rats and assessing differences in response to pharmacological agents". Neuroscience Letters, 755.
dc.identifier.doi10.1016/j.neulet.2021.135913
dc.identifier.eissn1872-7972
dc.identifier.issn0304-3940
dc.identifier.pubmed33895274
dc.identifier.scopus2-s2.0-85105830205
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0304394021002913
dc.identifier.urihttps://hdl.handle.net/11452/39466
dc.identifier.volume755
dc.identifier.wos000647707400002
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier Ireland
dc.relation.bapHDP (T) 2011/8
dc.relation.collaborationSanayi
dc.relation.journalNeuroscience Letters
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPrepulse inhibition
dc.subjectSchizophrenia
dc.subjectApomorphine
dc.subjectAmphetamine
dc.subjectMK-801
dc.subjectScopolamine
dc.subjectNicotine
dc.subjectCaffeine
dc.subjectRat
dc.subjectD-aspartate receptors
dc.subjectLow gating humans
dc.subjectStartle reflex
dc.subjectSchizophrenia
dc.subjectClozapine
dc.subjectGlutamate
dc.subjectNicotine
dc.subjectInvolvement
dc.subjectDeficits
dc.subjectImpact
dc.subjectNeurosciences & neurology
dc.subject.emtreeAmphetamine
dc.subject.emtreeApomorphine
dc.subject.emtreeCaffeine
dc.subject.emtreeDizocilpine
dc.subject.emtreeNicotine
dc.subject.emtreeScopolamine
dc.subject.emtreeAmino acid receptor blocking agent
dc.subject.emtreeAmphetamine
dc.subject.emtreeApomorphine
dc.subject.emtreeCentral stimulant agent
dc.subject.emtreeCholinergic receptor blocking agent
dc.subject.emtreeDizocilpine maleate
dc.subject.emtreeDopamine receptor stimulating agent
dc.subject.emtreeNicotine
dc.subject.emtreeNicotinic agent
dc.subject.emtreeScopolamine
dc.subject.emtreeAdult
dc.subject.emtreeAnimal experiment
dc.subject.emtreeAnimal model
dc.subject.emtreeArticle
dc.subject.emtreeControlled study
dc.subject.emtreeDrug megadose
dc.subject.emtreeDrug response
dc.subject.emtreeLow drug dose
dc.subject.emtreeMale
dc.subject.emtreeMonoaminergic system
dc.subject.emtreeNonhuman
dc.subject.emtreePrepulse inhibition
dc.subject.emtreePriority journal
dc.subject.emtreeRat
dc.subject.emtreeSchizophrenia
dc.subject.emtreeStartle reflex
dc.subject.emtreeAnimal
dc.subject.emtreeAuditory stimulation
dc.subject.emtreeDrug effect
dc.subject.emtreePhysiology
dc.subject.emtreePrepulse
dc.subject.emtreeİnhibition
dc.subject.emtreeProcedures
dc.subject.emtreeSprague dawley rat
dc.subject.meshAcoustic stimulation
dc.subject.meshAmphetamine
dc.subject.meshAnimals
dc.subject.meshApomorphine
dc.subject.meshCaffeine
dc.subject.meshCentral nervous system stimulants
dc.subject.meshCholinergic antagonists
dc.subject.meshDizocilpine maleate
dc.subject.meshDopamine agonists
dc.subject.meshExcitatory amino acid antagonists
dc.subject.meshMale
dc.subject.meshMale
dc.subject.meshNicotinic agonists
dc.subject.meshPrepulse inhibition
dc.subject.meshRats
dc.subject.meshRats, sprague-dawley
dc.subject.meshReflex, startle
dc.subject.meshScopolamine
dc.subject.scopusPrepulse Inhibition; Startle Reflex; Sensory Gating
dc.subject.wosNeurosciences
dc.titlePrepulse inhibition based grouping of rats and assessing differences in response to pharmacological agents
dc.typeArticle
dc.wos.quartileQ3 (Neurosciences)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Tıbbi Farmakoloji Ana Bilim Dalı
local.indexed.atWOS
local.indexed.atScopus
local.indexed.atPubMed

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama